Early-Phase Clinical Trial Leads To One Death And Five Hospitalizations In France

Pharmaceuticals: Scientists speculate about what went wrong based on what little information Portuguese firm Bial has released about its enzyme inhibitor

via Chemical & Engineering News: Biological SCENE http://ift.tt/1RXhutT